Dr. Srivastava has a distinguished background in stem cell biology, protein biochemistry, molecular biology, immunology, tissue targeting and gene therapy with the vision to provide stem cell-based therapies to the populations suffering from genetic or degenerative diseases around the world. Dr. Srivastava demonstrates expertise in ongoing research and development of stem cell-based therapies in clinical settings as Chairman and Co-founder of California based Global Institute of Stem Cell Therapy and Research (GIOSTAR).
Dr. Anand Srivastava’s mission is aligned with Cellebration’s goal to provide treatment for congenital, inherited, degenerative and autoimmune diseases at an established operating clinical as well as in a diabetes clinical trial setting. Dr. Srivastava has been associated with leading universities in the United States and has presented at international conferences in India, Japan, Germany and the United States with emphasis on the effective treatments of stem cell based therapies applicable to a wide spectrum of human diseases and suffering degenerative conditions.